Pediatric Hematology/Oncology Fellowship at Joseph M. Sanzari Children’s Hospital


A state-of-the-art child and family friendly facility and principal teaching hospital for the new Hackensack Meridian School of Medicine at Seton Hall University. This three-year training program prepares our graduates to become academic clinicians or clinician scientists.

Our Campus


  • Full service, state-designated Children’s Hospital
  • First neonatal ICU in the state of NJ to earn Disease Specific Care (DSC) certification in prematurity
  • One of the top 50 Children’s Hospitals for pediatric cancer, pediatric neurology, and pediatric neurosurgery nationwide, ranked by U.S. News & World Report
  • 100+ full-time faculty in general pediatrics and all pediatric medical and surgical subspecialties
  • 30 pediatric subspecialties
  • 48-bed Regional Perinatal Center
  • 15-bed Pediatric Intensive Care Unit (PICU)
  • 28-bed General Pediatric Unit
  • 16-bed Hematology/Oncology Unit
  • 6-bed Epilepsy Monitoring inpatient units

HMH Pediatric Hematology - Oncology Fellowship Program Video


Fellowship Administrative Leadership

Meet Our Faculty


Hematology/Oncology Faculty


Burton Appel, M.D., MBA, FAAP

Associate Director, Pediatric Hematology/Oncology
Chair, Data Safety Monitoring Board, Hackensack University Medical Center
Associate Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: University of Chicago, Pediatrics
Fellowship: University of Chicago, Pediatric Hematology/Oncology
Research Interest: Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Onco-fertility

Katherine Armstrong, M.D.

Residency: NYP Weill Cornell Medicine/Komansky Children’s Hospital, Pediatrics
Fellowship: Memorial Sloan Kettering Cancer Center/NYP Weill Cornell Medicine, Pediatric Hematology/Oncology
Research Interest: Hematology, Coagulation, Clinical Research

Jing Chen, M.D.

Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: University of Rochester Medical Center, Pediatrics
Fellowship: NYP Columbia University Medical Center/Morgan Stanley Children’s Hospital, Pediatric Hematology/Oncology
Research Interest: Acute Myeloid Leukemia, Cancer Genetics, Precision Medicine, Early Phase Trials for Leukemia

Steven Diamond, M.D.

Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: Mt. Sinai Medical Center, Pediatrics
Fellowship: Beth Israel Medical Center, Pediatric Hematology/Oncology
Research Interest: Hematology, Blood Banking, Sickle Cell Disease, Coagulation, LCH
Organizations/Affiliations: Chair, New Jersey Newborn Screening – Hemoglobinopathies

Derek Hanson, M.D.

Director of Pediatric Neuro-oncology Program
Chair, IRB, Hackensack University Medical Center
Director, Brain Tumor Research, Joseph M. Sanzari Children’s Hospital
Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: Jefferson Medical College/Alfred A.I. DuPont Hospital for Children, Pediatrics
Fellowship: Cohen Children’s Medical Center at Long Island Jewish Medical Center, Pediatric Hematology/Oncology
Research Interest: Brain tumors, Phase I Trials

Jennifer Krajewski, M.D.

Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Hematology/Oncology Chair, Solutions for Safety Committee, Joseph M. Sanzari Children’s Hospital
Residency: Children’s National Medical Center, Pediatrics
Fellowship: NYP Columbia University Medical Center/Morgan Stanley Children’s Hospital, Pediatric Stem Cell Transplant
Research Interest: Stem Cell Transplant for Sickle Cell Disease and Thalassemia, GVHD, Reducing Infections in Immunocompromised Patients, COVID-19 in the Immunocompromised Patient
Organizations/Affiliations: Co-chair, outreach and advocacy for STAR consortium

Michael Harris, M.D.

Section Chief, Survivorship
Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: Children’s Hospital of Philadelphia, Pediatrics
Fellowship: Children’s Hospital of Philadelphia, Pediatric Hematology/Oncology
Research Interest: Solid tumors, Late effects

Jessica Scerbo, M.D.

Director, Pediatric Hematology/Oncology, Jersey Shore Medical Center
Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: Schneider Children’s Hospital at Long Island Jewish Medical Center, Pediatrics
Fellowship: Cohen Children’s Medical Center at Long Island Jewish Medical Center, Pediatric Hematology/Oncology
Research Interest: AYA

Andrew Silverman, M.D.

Residency: NYP Columbia University Medical Center/Morgan Stanley Children’s Hospital, Pediatrics
Fellowship: NYP Columbia University Medical Center/Morgan Stanley Children’s Hospital, Pediatric Hematology/Oncology
Research Interest: Solid tumors, Immunotherapies

Bruce Terrin, M.D.

Residency: Mt. Sinai Medical Center, Pediatrics
Fellowship: Medical College of Virginia, Pediatric Hematology/Oncology
Research Interest: Hematology

Johannes Zakrzewski, M.D.

Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine
Residency: SUNY Downstate, Pediatrics
Fellowship: Memorial Sloan Kettering Cancer Center, Pediatric Hematology/Oncology, Pediatric Stem Cell Transplant
Research Interest: Stem Cell Transplant, Hematologic Malignancies, GVHD, T-cell Development

Curriculum


Year 1

The first year of fellowship is primarily devoted to clinical training. Fellows will develop the clinical and procedural skills to evaluate, diagnose and treat children, adolescents and young adults with a variety of blood disorders and malignancies. Fellows are assigned one day a week in their outpatient continuity clinic where they are encouraged to develop and maintain long-term professional relationships with the patients (and their families) they follow on a regular basis, to be involved in the day-to-day care of patients, and to be a part of the decision-making team. The fellows spend six, 4-week blocks on the inpatient hematology/oncology or Bone Marrow Transplant (BMT) services where they will be responsible for the care of admitted patients under the supervision of an attending physician. They will also spend six, 4-week blocks in the outpatient clinic/infusion center as well as on specialty rotations including hematopathology, blood bank, coagulation, cytogenetics, neurosurgery, and radiation oncology.

During the second half of year one, the fellow will meet with the program director to identify a research project and research mentor to begin a research project during the second year. A Scholarly Oversight Committee (SOC) is established for each fellow after finalization of the research project. The fellow, research mentor, program director, and SOC meet every six months or more often, as needed, to review the progress of the fellow in their research project.

Year 2

The second year is primarily devoted to the development of a laboratory or clinical research project. Fellows will have the opportunity to work in one of the basic science or translational research laboratories at the Center for Discovery and Innovation at the Hackensack Meridian School of Medicine at Seton Hall University. Alternatively, they may also choose to create their own clinical research project under the mentorship of the clinical faculty at Hackensack Meridian Health, working in a variety of subspecialty areas. Fellows will continue to have weekly continuity clinic as well as weekend and overnight call and attendance at divisional conferences. During the second year, they will become more independent in the care of their patients.

Year 3

During the third year, the fellow spends the majority of their time completing their research project, culminating in a scholarly product such as a grant proposal or publication. The fellow also continues with their once a week outpatient continuity clinic, call, and attends important divisional conferences. By the end of the third year, fellows should have completed their board eligibility requirements. Fellows will also spend this year seeking out and applying for job opportunities and developing their careers with the support of the program’s faculty.

Educational Conferences


Conference Frequency
Pediatric Oncology
Tumor Board
Weekly
Pediatric Neuro-oncology
Tumor Board
Monthly
Pediatric Molecular
Tumor Board
Monthly
Pediatric
Hematology Board
Monthly
Multidisciplinary Patient
Care Conference
Weekly
Journal Club Monthly
Bioethics Conference Quarterly
Protocol Review Quarterly
Center for Discovery
and Innovation (CDI) Lecture Series*
Weekly
Quality Conference
/Morbidity & Mortality
Quarterly
Core Curriculum
Lecture Series
Weekly
Pediatric Hematology
/Oncology Board Review
Monthly
Research Course Series Quarterly
Fellows Meeting Monthly
Pediatric Grand Rounds Weekly

* Center for Discovery and Innovation (CDI) lecture series: Renowned researchers and guest speakers present monthly basic and translational science lectures on site at the CDI. Fellows will have the opportunity to attend either in person or remotely.

Fellows will also have the opportunity to attend national meetings, including the American Society of Hematology, the American Society of Clinical Oncology, the American Association for Cancer Research, the American Society for Blood and Marrow Transplantation, and the American Society of Pediatric Hematology/Oncology. Funding is provided to attend national meetings and fellows are encouraged to submit abstracts of their work for presentation.

Research & Innovation


Throughout their three years of training, fellows are provided with exposure to a broad range of research opportunities that can be tailored to their personal professional goals, including clinical, translational, or basic science research. Fellows are provided with the mentorship, resources, and seminars to develop skills necessary to achieve these goals and to prepare them for their chosen careers.

Laboratory Research: Fellows who choose to have a basic science or translational research project have the opportunity to work in a number of research laboratories at the Center for Discovery and Innovation (CDI) at the Hackensack Meridian School of Medicine at Seton Hall University.

Mentors for the fellows include full-time, principal investigators of laboratories as well as Hackensack Meridian Health clinical faculty who have ongoing research projects at the CDI. Fellows choosing this pathway will have the opportunity to be active members of their chosen laboratory, attending journal clubs and laboratory meetings, and pursuing independent research projects under the supervision of their mentors.

Clinical Research: Fellows choosing to pursue a clinical research project will have the opportunity to work under the supervision of clinical faculty at Hackensack Meridian Health. They will learn the process of clinical trial development from inception to implementation and data analysis. In addition, all fellows will have exposure to the many open study protocols throughout the division. These include protocols sponsored through consortiums such as the Children’s Oncology Group and Beat Childhood Cancer, as well as industry-sponsored and investigator driven clinical trials.

Center for Discovery and Innovation (CDI)


The Center for Discovery and Innovation (CDI) resides in 58,000 GSF of newly renovated space with core facilities including high-end imaging, mass spectrometry, gene editing, cell sorting, flow cytometry, tissue banks and biocontainment. The high-tech auditorium, Board Room and video conferencing center serve as venues for speakers to present their research to CDI scientists, professors and medical students. An additional ~60,000 GSF of lab space is available for fellows to be active members of their chosen laboratory, attend journal clubs and laboratory meetings, and pursue independent research projects under the supervision of their mentors.

CDI Research

Clinical Rotations


All clinical training consists of rotations at Joseph M. Sanzari Children’s Hospital (JMSCH) with inpatient rotations being done at our Pediatric Hematology/Oncology/Stem Cell transplant unit consisting of 16 beds and a Pediatric Critical Care Unit consisting of 15 beds.

Fellow will be exposed to a variety of clinical diagnoses and therapies which include:

  • Stem cell transplant
  • Cellular therapies including CAR-T
  • Gene therapy
  • Early phase chemotherapy trials

Fellows will round on approximately 15 inpatients with a primary diagnosis of Pediatric Hematology/Oncology or Stem Cell Transplantation. Additionally, fellows will also be responsible for 1-3 consults in JMSCH.

For outpatient rotations, the Reuten Clinic for Hematology and Oncology has a dedicated chemotherapy/infusion area staffed by chemotherapy certified nurses and an area where pediatric anesthesiologists perform sedation for patients requiring procedures. We also have a pediatric photopheresis program. The fellows can participate in the care of the 20-30 patients seen in the Reuten Clinic and infusion area daily. Fellows will be responsible for a total of 10-20 primary patients during continuity clinic.

Fellows will be able to do the following outpatient rotations:

  • Neurooncology/Neurosurgery
  • Radiation Oncology
  • Blood bank/Coagulation
  • Hematopathology/Cytogenetics/Immunogenetics
  • Pediatric Pain and Palliative Care
  • Survivorship

Fellows gain most of their clinical training in the first year of training.

Contact Us